189 related articles for article (PubMed ID: 12967864)
1. Pars plana vitrectomy for epiretinal membrane associated with sarcoidosis.
Kiryu J; Kita M; Tanabe T; Yamashiro K; Ieki Y; Miura S; Miyahara S; Tamura H; Honda Y
Jpn J Ophthalmol; 2003; 47(5):479-83. PubMed ID: 12967864
[TBL] [Abstract][Full Text] [Related]
2. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis.
Kiryu J; Kita M; Tanabe T; Yamashiro K; Miyamoto N; Ieki Y
Ophthalmology; 2001 Jun; 108(6):1140-4. PubMed ID: 11382643
[TBL] [Abstract][Full Text] [Related]
3. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment.
Ieki Y; Kiryu J; Kita M; Tanabe T; Tsujikawa A; Yamashiro K; Miyamoto N; Miura S; Honda Y
Ocul Immunol Inflamm; 2004 Mar; 12(1):35-43. PubMed ID: 15209462
[TBL] [Abstract][Full Text] [Related]
4. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis.
Dev S; Mieler WF; Pulido JS; Mittra RA
Ophthalmology; 1999 Jun; 106(6):1086-90. PubMed ID: 10366075
[TBL] [Abstract][Full Text] [Related]
5. SURGICAL OUTCOMES IN PATIENTS WITH MACULAR PUCKER AND GOOD PREOPERATIVE VISUAL ACUITY AFTER VITRECTOMY WITH MEMBRANE PEELING.
Reilly G; Melamud A; Lipscomb P; Toussaint B
Retina; 2015 Sep; 35(9):1817-21. PubMed ID: 25923959
[TBL] [Abstract][Full Text] [Related]
6. Surgical Outcomes of Epiretinal Membranes in Patients with a History of Well-Controlled Preoperative Uveitis.
Rao P; Todorich B; Yonekawa Y; Wang J; Sobrin L; Faia LJ
Ophthalmol Retina; 2018 Mar; 2(3):192-196. PubMed ID: 31047584
[TBL] [Abstract][Full Text] [Related]
7. Pars plana vitrectomy in patients with intermediate uveitis.
Stavrou P; Baltatzis S; Letko E; Samson CM; Christen W; Foster CS
Ocul Immunol Inflamm; 2001 Sep; 9(3):141-51. PubMed ID: 11815883
[TBL] [Abstract][Full Text] [Related]
8. Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis.
Tanawade RG; Tsierkezou L; Bindra MS; Patton NA; Jones NP
Retina; 2015 Apr; 35(4):736-41. PubMed ID: 25462433
[TBL] [Abstract][Full Text] [Related]
9. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
[TBL] [Abstract][Full Text] [Related]
10. Anatomic and functional outcome after surgical removal of idiopathic macular epiretinal membrane.
Lee PY; Cheng KC; Wu WC
Kaohsiung J Med Sci; 2011 Jul; 27(7):268-75. PubMed ID: 21757144
[TBL] [Abstract][Full Text] [Related]
11. [Vitrectomy for idiopathic and secondary preretinal macular membrane].
Oficjalska-Młyńczak J; Jamrozy-Witkowska A
Klin Oczna; 2004; 106(1-2):35-8. PubMed ID: 15218762
[TBL] [Abstract][Full Text] [Related]
12. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
[TBL] [Abstract][Full Text] [Related]
13. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
14. Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema.
Avci R; Kaderli B; Avci B; Simsek S; Baykara M; Kahveci Z; Gelisken O; Yucel AA
Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):845-52. PubMed ID: 15221309
[TBL] [Abstract][Full Text] [Related]
15. Macular edema following cataract surgery in eyes with previous 23-gauge vitrectomy and peeling of the internal limiting membrane.
Mylonas G; Sacu S; Deák G; Dunavoelgyi R; Buehl W; Georgopoulos M; Schmidt-Erfurth U;
Am J Ophthalmol; 2013 Feb; 155(2):253-259.e2. PubMed ID: 23036567
[TBL] [Abstract][Full Text] [Related]
16. Vitrectomy for epiretinal membranes with good visual acuity.
Thompson JT
Trans Am Ophthalmol Soc; 2004; 102():97-103; discussion 103-5. PubMed ID: 15747749
[TBL] [Abstract][Full Text] [Related]
17. PARS PLANA VITRECTOMY FOR SYMPTOMATIC EPIRETINAL MEMBRANES IN EYES WITH 20/50 OR BETTER PREOPERATIVE VISUAL ACUITY.
Lehpamer BP; Carvounis PE
Retina; 2015 Sep; 35(9):1822-7. PubMed ID: 25874367
[TBL] [Abstract][Full Text] [Related]
18. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study.
Dugel PU; Rao NA; Ozler S; Liggett PE; Smith RE
Ophthalmology; 1992 Oct; 99(10):1535-41. PubMed ID: 1454319
[TBL] [Abstract][Full Text] [Related]
19. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.
Rosenblatt BJ; Shah GK; Sharma S; Bakal J
Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):20-5. PubMed ID: 15290152
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
